Recherche

POLE HOSPITALIER
PSYCHIATRIE UNIVERSITAIRE


CHEF DE PÔLE : AZORIN Jean-Michel
ADRESSE : SHU Psychiatrie Adultes – Hôpital Ste Marguerite 13274 Marseille Cedex 9 TELEPHONE : 04 91 74 40 82 COURRIEL : jazorin@ap-hm.fr ECOLE DOCTORALE : Sciences de la Vie et de la Santé DISCIPLINES D’APPARTENANCES : 4903 , 4904 SPECIALITÉS : Psychiatrie d’Adultes, Psychiatrie de l’Enfant et de l’Adolescent, Addictologie, EFFECTIFS

Enseignants-Chercheurs (PU-PH, MCU-PH, CCA, AHU) :
PERSONNELS RATTACHÉS A UNE EQUIPE DE RECHERCHE
Pôle hospitalier. Psychiatrie Universitaire SERVICES HOSPITALIERS
INTITULÉ : PSYCHIATRIE ADULTES RESPONSABLE : PR. JM AZORIN RESPONSABLE : PR. J NAUDIN DISCIPLINE : 4903 RESPONSABLE : PR. LANCON DISCIPLINE : 4903 RESPONSABLE : PR. N. SIMON - PR. C. LANCON DISCIPLINE : 4903 INTITULÉ : PSYCHIATRIE DE l’ENFANT ET DE L’ADOLESCENT RESPONSABLE : PR. F. POINSO INTITULÉ : PSYCHIATRIE DE l’ENFANT ET DE L’ADOLESCENT RESPONSABLE : PR. D. DA FONSECA DISCIPLINE : 4904 PUBLICATIONS ANNÉES 2010 et 2011
Année 2010
Abdel Rassoul R, Alves S, Pantesco V, De Vos J, Michel BF, Perret M, Mestre-Frances N, Verdier JM, Devau G. Distinct expression of the temporal cortex of the primate Microcebus murinus during brain aging versus Alzheimer’s disease-like pathology – PloS One – 2010 – 5 – pii : e12770 Adida M, Richieri R, Maurel M, Kaladjian A, Da Fonseca D, Bottai T, Fakra E, Pringuey D, Azorin JM. Affective disorders, antipsychotics and mood stabilizers: therapeutic innovations – Encephale – Azorin JM. Affective disorders: From new models to novel treatments – Encephale – 2010 – 36 Suppl 6: S155-6 Azorin JM. Beginning bipolar disorder - Encephale – 2010 – 36 Suppl 1: S1-2 Azorin JM, Kaladjian A, Fakra E, Da Fonseca D, Adida M, Maurel M, Richieri R, Bottai T, Pringuey D. Gene-environment interactions in affective disorders – Encephale – 2010 – 36 Suppl 6 : S167-72 Azorin JM, Kaladjian A, Fakra E, Adida M. Sertindole for the treatment of schizophrenia – Expert Opin Pharmacother – 2010 – 11 : 3053-64 BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. Lithium plus valproate therapy versus monotherapy for relapse prevention in bipolar disorder (BALANCE) : a randomized open-label trial – Lancet – 2010 – 30;375 : 385-95 Pôle hospitalier. Psychiatrie Universitaire Bailly D. Issues related to consent to healthcare decisions in children and adolescents – Arch Pediatr – 2010 – 17 Suppl 1: S7-15 Belzeaux R, Formisano-Tréziny C, Loundou A, Boyer L, Gabert J, Samuelian JC, Féron F, Naudin J, Ibrahim EC. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression – J Psychiatr Res. – 2010 – 44: 1205-13 Besnier N, Fakra E, Kaladjian A, Adida M, Maurel M, Azorin JM. Depressive onset episode of bipolar disorder: clinical and prognostic considerations – Encephale – 2010 – 36 Suppl 1: S18-22 Besnier N, Cassé-Perrot C, Jouve E, Nguyen N, Lançon C, Falissard B, Blin O. Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians – Psychopharmacology (Berl) – 2010 – 207: 619-29 Bottai T, Biloa-Tang M, Christophe S, Dupuy C, Jacquesy L, Kochman F, Meynard JA, Papeta D, Rahioui H, Adida M, Fakra E, Kaladjian A, Pringuey D, Azorin JM. Interpersonal and social rhythm therapy (IPSRT) – Encephale – 2010 – 36 Suppl 6: S206-17 Boulamery A, Simon N, Vidal J, Bruguerolle B. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study – Chronobiol Int. 2010 – 27: 251-64 Boyer L, Belzeaux R, Maurel O, Baumstarck-Barrau K, Samuelian JC. A social network analysis of healthcare professional relationships in a French hospital – Int J Health Care Qual Assur – 2010 – Boyer L, Murcia A, Belzeaux R, Loundou A, Azorin JM, Chabannes JM, Dassa D, Naudin J, Samuelian JC, Lançon C. Psychometric properties of the Activities Daily Life Scale (ADL) – Boyer L, Simeoni MC, Loundou A, D’Amato T, Reine G, Lançon C, Auquier P. The development of the S-QoL 18 : a shortened quality of life questionnaire for patients with schizophrenia – Schizophr Res. – 2010 – 121 : 241-50 Brousse G, Meary A, Blanc O, Lançon C, LLorca PM, Leboyer M. Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia - Psychiatr Res. – 2010 – 30;179 : Broustal O, Camuzat A, Guillot-Noël L, Guy N, Millecamps S, Deffond D, Lacomblez L, Golfier V, Hannequin D, Salachas F, Camu W, Didic M, Dubois B, Meininger V, Le Ber I, Brice A, French clinical and genetic research network on FTD/FTD-MND. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis – J Alzheimers Dis. – 2010 – 22: 765-9 Brunet P, Simon N, Roubicek C, Papa K, Berland Y, Bruguerolle B. Manufacturing waste of hemodialyzers decreases oxidative phosphorylation of mitochondria isolated from rats – Nephrol Cermolacce M, Sass L, Parnas J. What is bizarre in bizarre delusions? A critical review – Schizophr Bull. – 2010 – 36: 667-79 Da Fonseca D, Bat F, Rouviere N, Campredon S, Bastard-Rosset D, Viellard M, Santos A, Deruelle C, Azorin JM, Fakra E, Adida M. Bipolar disorder : Continuity from child to adult ? – Encephale – Da Fonseca D, Cury F, Santos A, Sarrazin P, Poinso F, Deruelle C. How to increase academic performance in children with oppositional defiant disorder? An implicit theory effect – Journal of Behavior Therapy and Experimental Psychiatry – 2010 – 41: 234-237 Fakra E, Azorin JM, Adida M, Da Fonseca D, Kaladjian A, Pringuey D. Affective disorders and antidepressant drugs : Therapeutic innovations – Encephale – 2010 – 36 Suppl 6 : S183-7 Fakra E, Kaladjian A, Da Fonseca D, Maurel M, Adida M, Besnier N, Pringuey D, Azorin JM. Prodromal phase in bipolar disorder – Encephale – 2010 – 36 Suppl 1: S8-12 Gavaudan G, Magalon D, Cohen J, Lançon C, Léonetti G, Pélissier-Alicot AL. Partial agonist therapy in schizophrenia: relevance to diminished criminal responsability – J Forensic Sci. – 2010 – 55: Pôle hospitalier. Psychiatrie Universitaire Ghanim M, Guillot-Noël L, Pasquier F, Jornea L, Deramecourt V, Dubois B, Le Ber I, Brice A, French Research Network on FTD and FTD/MND. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration – J Neurol. – 2010 – 257: 2032-6 Guillet BA, Simon NS, Purgus R, Botta C, Morange S, Berland Y, Pisano PS. Population pharmacokinetics analysis of mycophenotic acid in adult kidney transplant patients with chronic graft dysfunction – Ther Drug Monit. 2010 – 32: 427-32 Henry JM, Boyer L, Belzeaux R, Baumstarck-Barrau K, Samuelian JC. Mental disorders among homeless people admitted to a French psychiatric emergency service – Psychiatr Serv. – 2010 – Heuzey A, Bonnet A, Parola N, Cohen J, Lançon C. Mise en place d’un profil cognitivo- comportemental chez des sujets boulimiques – Int J Health Care Qual Assur - 2010 – 23 : 460-9 Kaladjian A, Azorin JM, Adida M, Fakra E, Da Fonseca D, Pringuey D. Affective disorders: Evolution of nosographic models – Encephale – 2010 – 36 Suppl 6: S178-82 Kaladjian A, Fakra E, Adida M, Besnier N, Maurel M, Azorin JM. Manic polarity of the onset episode of bipolar disorder: clinical and prognostic considerations – Encephale – 2010 – 36 Suppl 1: S13-7 Lemogne C, Ledru F, Bonierbale M, Consoli SM. Erectile dysfunction and depressive mood in men with coronary heart disease – Int J Cardiol. – 2010 – 4; 138: 277-80 LLorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, Baylé F, Hamon M, Lançon C, Thibaut F, Thomas P, Lancrenon S, Samalin L ; l’Association Française de Psychiatrie Biologique et Neuropsychopharmacologique (AFPBN). Screening and management of bipolar disorders: results – Encephale – 2010 – 36 Suppl 4: S86-102 LLorca PM, Courtet P, Martin P, Abbar M, Gay C, Meynard JA, Baylé F, Hamon M, Lançon C, Thibaut F, Thomas P, Lancrenon S, Guillaume S, Samalin L. Screening and management of bipolar disorders : methodology – Encephale – 2010 – 36 Suppl 4 : S79-85 Maurel M, Azorin JM, Adida M, Fakra E, Richieri R, Bottai T, Pringuey D, Kaladjian A. Bipolar affective disorders : models and assessment of psychological treatments – Encephale – 2010 – 36 Suppl 6 : S202-5 Maurel M, Kaladjian A, Fakra E, Besnier N, Adida M, Azorin JM. Treatment of a first manic episode – Encephale – 2010 – 36 Suppl 1: S23-6 Lançon C. Depression and health state – Encephale – 2010 – 36 Suppl 5: S112-6 Meguerditchian C, Samuelian-Massat C, Valero R, Begu-Le Corroller A, Fromont I, Mancini J, Sparrow J, Poinso F, Vialettes B. Inpatient treatment and anorexia nervosa outcomes – e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism – 2010 – 5 : e40-e44 Michel BF, Luciani V, Geda YE, sambuchi N, Paban V, Azorin JM. In Alzheimer’s disease, the clinical expression of behavorial and psychological signs and symptoms is early and specific of neuropathological stages – Encephale – 2010 – 36: 314-25 Pringuey D, Fakra E, Cherikh F, Bottai T, Tible O, Maurel M, Richieri R, Adida M, Kaladjian A, Azorin JM. Affective disorders: News in chronobiological models – Encephale – 2010 – 36 Suppl 6: S157-66 Richieri R, Adida M, Dumas R, Fakra E, Azorin JM, Pringuey D, Lançon C. Affective disorders and repetitive transcranial magnetic stimulation : therapeutic innovations – Encephale – 2010 – 36 Suppl 6 : S197-201 Rosset DB, Santos A, Da Fonseca D, Poinso F, O’Connor K, Deruelle C. Do children perceive features of real and cartoon faces in the same way? Evidence from typical development and autism – J Clin Exp Neuropsychol. – 2010 – 32: 212-8 Salgado-Pineda P, Fakra E, Delaveau P, Hariri AR, Blin O. Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. J Psychiatry Neurosci – 2010 – 35: 41-8 Pôle hospitalier. Psychiatrie Universitaire Simon N, Castinetti F, Ouliac F, Lesavre N, Brue T, Oliver C. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets – Clin Pharmacokinet – 2010 – 49 : 455-63 Année 2011
Abraham JD, Calvayrac-Pawlowski S, Cobo S, Salvetat N, Vicat G, Molina L, Touchon J, Michel BF, Molina F, Verdier JM, Fareh J, Mourton-Gilles C. Combined measurement of PEDF haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between Alzheimer’s disease and other dementias – Biomarkers – 2011 – 16 : 161-71 Adida M, Maurel M, Kaladjian A, Fakra E, Lazerges P, Da Fonseca D, Belzeaux R, Cermolacce M, Azorin JM. Decision-making and schizophrenia – Encephale – 2011 – 37 Suppl 2: S110-6 Adida M, Jolant F, Clark L, Besnier N, Guillaume S, Kaladjian A, Mazzola-Pomietto P, Jeanningros R, Goodwin GM, Azorin JM, Courtet P. Trait-related decision-making impairment in the three phases of bipolar disorder – Biol Psychiatry – 2011 – 15;70 : 357-65 Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C. Relationship between insight and self- reported quality of life among schizophrenic patients – Encephale – 2011 – 37 : 162-71 Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH, BRIDGE Study Group. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study – Arch Gen Psychiatry – 2011 – 68: 791-8 Azorin JM. Major depression: features indicative of bipolarity? – Encephale – 2011 – 37 Suppl 3: Azorin JM, Da Fonseca D, Fakra E. Schizophrenia and cognition: long standing and current issues – Encephale – 2011 – 37 Suppl 2: S93-4 Azorin JM, Kaladjian A, Adida M, Fakra E, Hantouche E, Lancrenon S. Baseline and prodromal characteristics of first-versus multiple-episode mania in a French cohort of bipolar patients – Eur Psychiatry – 2011 – 1 Baylé FJ, Blanc O, De Chazeron I, Lesturgeon J, Lançon C, Caci H, Garay RP, LLorca PM. Pharmacological management of anxiety in patients suffering from schizophrenia – Encephale – Bellivier F, Etain B, Malafosse A, Henry C, Kahn JP, Elgrabil-Wajsbrot O, Jamain S, Azorin JM, Franck E, Scott J, Grochocinski V, Kupfer DJ, Golmard JL, Leboyer M. Age at onset in bipolar affective disorder in the USA and Europe – World J Biol Psychiatry – 2011 – 21 Bellivier F, Yon L, Luquiens A, Azorin JM, Bertsch J, Gerard S, Reed C, Lukasiewicz M. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM) – Bipolar Disord – 2011 – 13: 377-86 Belzeaux R, Ibrahim EC, Fakra E, Adida M, Cermolacce M, Azorin JM. Schizophrenia, genetics and cognition – Encephale – 2011 – 37 Suppl 2: S127-32 Bouloudnine S, Azorin JM, Petitjean F, Parry-Pousse P, Sciorato F, Blin O, Fakra E. Perception of atypical antipsychotics side effects through speech analysis of schizophrenic patients – Encephale – 2011 – 37 Suppl 2 : S 143-50 Boyadjiev I, Boulamery A, Simon N, Martin C, Bruguerolle B, Leone M. Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients – Antimicrob Agents Chemother – 2011 – 55 : 3573-5 Boyer L, Aghababian V, Richieri R, Loundou A, Padovani R, Simeoni M.C, Auquier P, Lançon C. Insight into illness, neurocognition and quality of life in schizophrenia – Prog Neuropsychopharmacol Biol Psychiatry – 2011 – 36 : 271-6 Pôle hospitalier. Psychiatrie Universitaire Boyer L, Dassa D, Belzeaux R, Henry JM, Samuelian JC, Baumstarck-Barrau K, Lançon C. Frequent visits to a French psychiatric emergency service: diagnostic variability in psychotic disorders – Psychiatr Serv. – 2011 – 62: 966-70 Boyer L, Dassa D, Lançon C. A case of porencephalic cyst in a schizophrenic patient with history of postnatal encephalitis – Prog Neuropsychopharmacol Biol Psychiatry – 2011 –15; 35: 288-9 Boyer L, Dassa D, Samuelian JC, Lançon C. Questions about the future French mental health finance – Encephale – 2011 – 37: 1-3 Buvat J, Montorsi F, Maggi M, Porst H, Kaipia A, Colson MH, Cuzin B, Moncada I, Martin-Morales A, Yassin A, Meuleman E, Eardley I, Dean JD, Shabsigh R. Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study) – J Sex Med. 2011 – 8 : Cano N, Boyer L, Garnier C, Michel A, Belzeaux R, Chabannes JM, Samuelian JC, Harle JR. Patients perception of seclusion in psychiatry : ethical perspectives – Encephale – 2011 – 37 Suppl 1 : S4- 10 Cermolacce M, Lazerges P, Da Fonseca D, Fakra E, Adida M, Belzeaux R, Azorin JM. Theory of mind and schizophrenia – Encephale – 2011 – 37 Suppl 2: S117-22 Cermolacce M, Micoulaud JA, Naudin J, Vion-Dury J. Electrophysiology and schizophrenic vulnerability : the P300 component as endophenotype candidate ? – Encephale – 2011 – 37: 353- 60 Cohen J, Magalon D, Boyer L, Simon N, Christophe L. Aripiprazole-induced pathological gambling: a report of 3 cases. Curr Drug Saf. – 2011 – 1; 6: 51-3 Correard N, Mazzola-Pomietto P, Elissalde SN, Vigilanese-Salmon N, Fakra E, Azorin JM. What perspectives for cognitive remediation in schizophrenia? – Encephale – 2011 – 37 suppl 2: S155-60 Da Fonseca D, Rosset D, Bat F, Campredon S, Rouviere N, Givaudan M, Fakra E, Azorin JM. Schizophrenia and cognition, a neurodevelopmental approach – Encephale – 2011 – 37 Suppl 2: S133-6 Da Fonseca D, Santos A, Rosset D, Deruelle C. The beauty is good for children with autistic spectrum disorders too - Research in Autism Spectrum Disorders – 2011 – 5: 299-304 Dumaine A, Maucuer A, Barbet A, Manceau V, Deshommes J, Méary A, Szöke A, Schürhoff F, LLorca PM, Lançon C, Leboyer M, Jamain S. Genetic and molecular exploration of UHMK1 in schizophrenic patients – Psychiatr Genet. – 2011 – 21: 315-8 Elissalde SN, Mazzola-Pomietto P, Vigilanese N, Correard N, Fakra E, Azorin JM. Schizophrenia, executive control and memory – Encephale – 2011 – 37 Suppl 2: S95-9 Fakra E, Kaladjian A, Adida M, Cermolacce M, Belzeaux R, Azorin JM. Schizophrenia, psychotropic drugs and cognition – Encephale – 2011 – 37 Suppl 2: S137-42 Glangeaud N.M.C, Sutter A.L, Thieulin A.C, Dagens-Lafont V, Zimmermann M ;A, Debourg A, Massari B, Cazas O, Camnas R, Rainelli C, Poinso F, Maron M, Nezelof S, Ancel P.Y, Khoshnood B – inpatient mother-and-child postpartum psychiatric care : Factors associated with improvement in maternal mental health – European Psychiatry – 2011 – 26 : 215-23 Gorincour G, Tassy S, Payot A, Philip N, Malzac P, Harlé JR, Mattei JF, Le Coz P. Decision-making in termination of pregnancy : a French perspective – Gynecol Obstet Fertil – 2011 – 39 : 198-204 Gorincour G, Tassy S, Quarello E, Piercecchi-Marti MD, Philip N. Stillbirth in high-income countries – Lancet – 2011 – 378 : 874 Gorincour G, Tassy S, Siméoni U, Le Coz P. Ethical issues on pregnancy termination: impact of new imaging modalities – Fetal Diagn Ther. – 2011 – 30: 1-8 Pôle hospitalier. Psychiatrie Universitaire Guilhaumou R, Simon N, Quarantia S, Verschuur A, Lacarelle B, André N, Solas C. Population pharmacokinetics and pharmacogenetics of vincristine in pediatric patients treated for solid tumour diseases – Cancer Chemother Pharmacol. – 2011 – 68: 1191-8 Guilhaumou R, Solas C, Bourgarel-Rey V, Quarantia S, Rome A, Simon N, Lacarele B, André N. Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity – Cancer Chemother Pharmacol. – 2011 – 68: Kaladjian A, Fakra E, Adida M, Belzeaux R, Cermolacce M, Azorin JM. Schizophrenia, cognition and neuroimaging – Encephale – 2011 – 37 suppl 2: S123-6 Lazerges PE, Cermolacce M, Fakra E, Tassy S, Azorin JM, Huguet P, Scott Kelso JA, Oullier O. Interpersonal sensorimotor coordination dynamics in schizophrenic patients: introducing a new experimental paradigm – Encephale – 2011 – 37 Suppl 2: S100-9 Maurel M, Belzeaux R, Adida M, Fakra E, Cermolacce M, Da Fonseca D, Azorin JM. Schizophrenia, cognition and psychoeducation – Encephale – 2011 – 37 Suppl 2: S151-4 Micoulaud-Franchi JA. One step more toward pharmacovigilance 2.0. Integration of web data community for a pharmacovigilance more alert – Presse Med. – 2011 – 40: 790-2 Micoulaud-Franchi JA, Aramaki M, Merer A, Cermolacce M, Ystad S, Kronland-Martinet R, Vion-Dury J. Categorization and timbre perception of environmental sounds in schizophrenia – Psychiatry Res. Micoulaud-Franchi JA, Bat-Pitault F, Da Fonseca D, Rufo M. Early onset schizophrenia and partial agenesis of corpus callosum – Arch Pediatr. – 2011 – 18: 189-92 Micoulaud-Franchi JA, Vion-Dury J. One step more toward new therapeutic options in brain stimulation: two models of EEG-based rTMS—from « EEG-contingent rTMS » to « EEG-biofeedback rTMS » - Brain Stimul. – 2011 – 4: 122-3 Millier A, Sarlon E, Azorin JM, Boyer L, Aballea S, Auquier P, Toumi M. Relapse according to antipsychotic treatment in schizophrenic patients : a propensity-adjusted analysis – BMC Psychiatry – 2011 – 11 : 11-24 Oudin C, Vialet R, Boulamery A, Martin C, Simon N. Vancomycin prescription in neonates and young infants : toward a simplified dosage – Arch Dis Child Fetal Neonatal Ed. – 2011 – 96 : 365-70 Richieri R, Boyer L, Reine G, Loundou A, Auquier P, Lançon C, Simeoni MC. The Schizophrenia Caregiver Quality of Life questionnaire (S-CGQoL) : development and validation of an instrument to measure quality of life of caregivers of individuals with schizophrenia – Schizophr Res. – 2011 – Richieri R, Boyer L, Lançon C. Analysis of the reliability of diagnostic criteria and classifications in psychiatry – Santé Publique – 2011 – 23 Suppl 6 : S31-8 Richieri R, Boyer L, Reine G, Loundou AD, Simeoni MC, Auquier P, Lançon C. A preliminary validation of a new French instrument to assess quality of life for caregivers of patients suffering from schizophrenia – Encephale – 2011 – 37: 425-32 Richieri R, Boyer L, Farisse J, Colavolpe C, Mundler O, Lançon C, Guedj E. Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression – Eur J Nucl Med Mol Imaging – 2011 – 38 : 1715-22 Rosset D, Santos A, Da Fonseca D, Rondan C, Poinso F, Deruelle C. More than just another face in the crowd: Evidence for an angry superiority effect in children with and without autism – Research in Autism Spectrum Disorders – 2011 – 5 : 949-956 Salgado-Pineda P, Fakra E, Delaveau P, McKenna PJ, Pomarol-Clotet E, Blin O. Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients – Pôle hospitalier. Psychiatrie Universitaire Tassy S. On the necessity to distinguishing judgment from subjective choice in the cognitive neuroscience of morality – Med Sci (Paris) – 2011 – 27: 889-94 Vercelletto M, Boutoleau-Bretonnière C, Volteau C, Puel M, Auriacombe S, Sarazin M, Michel BF, Couratier P, Thomas-Antérion C, Verpillat P, Gabelle A, Golfier V, Cerato E, Lacomblez L, French research network on frontotemporal dementia - Memantine in behavorial variant frontotemporal dementia : negative results - J Alzheimers Dis. – 2011 – 23 : 749-59 CONTRATS ANNÉES 2010 et 2011
JM AZORIN – J NAUDIN Etude des ARN messagers comme marqueurs biologiques sanguins de la dépression APHM-PHRC – 2010 C LANCON Etude par IRM conventionnelle et non conventionnelle des liens entre qualité de vie et aspects morphologiques structuraux et métaboliques dans la schizophrénie. APHM – PHRC- 2010. P AUQUIER Essai d’intervention randomisée évaluant l’efficacité de deux stratégies de prise en charge des personnes sans domicile souffrant d’une pathologie mentale sévère. APHM – PHRC – 2011, D DA FONSECA Evaluation des troubles psychopathologiques chez les enfants guéris d’un cancer. APHM, PHRC. 2011. L BOYER Rôle des phénomènes de réponse shift dans l’interprétation du lien entre la qualité de vie des patients souffrant de schizophénie et celle de leurs aidants APHM PHRC -2011. C BESCHE Interaction émotion-cognition à travers l’étude du langage littéral dans les troubles schizophréniques et bipolaires : approche comportementale et électrophysiologique. URCA – ANR -2011. THESES de DOCTORAT ANNÉES 2010 et 2011
Année 2010
BESNIER Nathalie. Aspects cognitifs et émotionnels de l’interférence aux tests de Stroop dans les troubles schizophréniques et bipolaires – 22/06/10 Année 2011
BELZEAUX Raoul. Etudes de l’expression des ARN périphériques dans la dépression. 19/12/11.


Pôle hospitalier. Psychiatrie Universitaire

Source: http://www.timone.univ-mrs.fr/medecine/recherche/Annuaire/2011/poles_hospitaliers/azorin.pdf